| [24] Streamlined large-scale production of recombinant adeno-associated virus (rAAV) vectors M Potter, K Chesnut, N Muzyczka, T Flotte, S Zolotukhin Methods in enzymology 346, 413-430, 2002 | 55 | 2002 |
| [48] Production and purification of recombinant adeno-associated virus WW Hauswirth, AS Lewin, S Zolotukhin, N Muzyczka Methods in enzymology 316, 743-761, 2000 | 208 | 2000 |
| 1032. rAAV Mediated Knock-Down of Tyrosine Hydroxylase in the Substantia Nigra Using a pol II Transcribed siRNA FP Manfredsson, RJ Mandel, S Zolotukhin, AS Lewin Molecular Therapy 13, S396, 2006 | | 2006 |
| 159. Sustained Weight Loss and Altered Lipid Taste Sensitivity Induced by Modulation of Salivary PYY and Excendin-4 in Mice SM Crosson, S Currlin, T Khan, CD Dotson, S Zolotukhin Molecular Therapy 24, S62-S63, 2016 | | 2016 |
| 26 Is There a Future for Gene S Zolotukhin Management of Chronic Viral Hepatitis, 315, 2002 | | 2002 |
| 304. Deriving Useful Data from Next-Gen Sequencing of AAV Capsid Libraries D Marsic, S Zolotukhin Molecular Therapy 23, S123, 2015 | | 2015 |
| 332. The Crystal Structure of AAV5: Role of Variable and Conserved Regions in Capsid Function L Govindasamy, M DiMattia, BL Gurda, R McKenna, JA Chiorini, ... Molecular Therapy 19, 1, 2011 | | 2011 |
| 371. Optimizing Capsid Composition for the Production of Recombinant Adeno-Associated Virus Using the Baculovirus Expression System K Erger, D Markusic, R Geguchadze, BJ Byrne, S Zolotukhin Molecular Therapy 18, 1, 2010 | | 2010 |
| 400. Successful Production of Pseudotyped Mosaic rAAV Vectors Using a Modified Baculovirus Expression System E Kohlbrenner, G Aslanidi, K Nash, S Shklayev, M Campbell-Thompson, ... Molecular Therapy, 155, 2005 | 2 | 2005 |
| 406. rAAV-Mediated Expression of Wnt10b cDNA Prevents the Development of Obesity in DIO Rats G Aslanidi, G Philipsberg, V Kroutov, K Lamb, E Kohlbrenner, ... Molecular Therapy 13, S156, 2006 | | 2006 |
| 418. rAAV-Mediated Expression of Adiponectin Receptor (AdipoR2) cDNA in Muscle Prevents the Development of Obesity in DIO Rats G Aslanidi, S Shklayev, E Kohlbrenner, V Kroutov, G Walter, ... Molecular Therapy, 162, 2005 | | 2005 |
| 420. Adaptation of Baculovirus System for Large-Scale Production of rAAV Vector Serotypes E Kohlbrenner, G Aslanidi, DR Knop, O Gorbatyuk, K Nash, RJ Mandel, ... Molecular Therapy 9 (S1), S161, 2004 | 1 | 2004 |
| 549. Fine Tuning of Transduction Efficiency of rAAV Vectors via Modulation of Capsid Composition O Kondratov, D Marsic, M Mietzsch, R Heilbronn, S Zolotukhin Molecular Therapy 24, S220, 2016 | 1 | 2016 |
| 566. V 566. Viral Vectors Based on ectors Based on ectors Based on AAV1, AAV2 and AAV5 Serotypes Display Disparate T Serotypes Display Disparate Transduction Patterns in … C Burger, S Zolotukhin, RJ Mandel, N Muzyczka Molecular Therapy 5 (5), 2002 | | 2002 |
| 61. Tyrosine Mutations in the Capsid of AAV Vectors Alters Transduction Properties in the Retina H Petrs-Silva, A Dinculescu, SH Min, L Zhong, S Zolotukhin, A Srivastava, ... Molecular Therapy 18, 1, 2010 | | 2010 |
| 723. AAV Mediated Cancer Targeting: Systemic Trafficking to Tumor Is More Important Than Vector Tumor Cell Interaction Y Lu, D Marsic, C Ling, MV Guijario, PP Levings, GD Palmer, A Dacanay, ... Molecular Therapy 24, S285, 2016 | | 2016 |
| A comprehensive study of a 29-capsid AAV library in a non-human primate central nervous system O Kondratov, L Kondratova, RJ Mandel, K Coleman, MA Savage, ... Molecular Therapy 29 (9), 2806-2820, 2021 | 44 | 2021 |
| A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis L Zhong, W Zhao, J Wu, B Li, S Zolotukhin, L Govindasamy, ... Molecular Therapy 15 (7), 1323-1330, 2007 | 198 | 2007 |
| A fluorescence video-endoscopy technique for detection of gene transfer and expression TR Flotte, SE Beck, K Chesnut, M Potter, A Poirier, S Zolotukhin Gene therapy 5 (2), 166-173, 1998 | 59 | 1998 |
| A guide to human gene therapy S Zolotukhin World Scientific, 2010 | 1 | 2010 |
